抵消免疫衰变 - - 哪些治疗策略是有前途的?
Christoph Hieber1,2, Stephan Grabbe1,2, Matthias Bros1
1Department of Dermatology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstraße 1, 55131 Mainz, Germany.
Biomolecules
|July 29, 2023
概括
老龄化削弱了免疫反应,增加了对感染和癌症的易感性. 这篇评论探讨了免疫衰变的原因和治疗策略,如纳米医学和老化药物,以恢复衰老和疾病中的免疫功能.
科学领域:
- 免疫学 免疫学 免疫学
- 老年学是一门学科.
- 在瘤学瘤学.
背景情况:
- 衰老会影响免疫系统对病原体的反应.
- 炎症性,增加基底促炎细胞因子,阻碍先天免疫和抗原呈现.
- 减少的天真淋巴细胞和升高的调控细胞进一步减弱了适应性免疫力.
研究的目的:
- 检查免疫发生的细胞和分子原因.
- 讨论衰老在慢性感染和癌症期间免疫逃避中的作用.
- 探索与年龄相关的免疫衰退的治疗干预措施.
主要方法:
- 文献审查的免疫性. 免疫性.
- 对用于癌症治疗的纳米配方药物的分析.
- 在临床试验中对纳米疫苗和老化剂的评估.
主要成果:
- 免疫性发生涉及受损的先天性和适应性免疫力.
- 衰老有助于慢性疾病中的免疫逃避.
- 纳米医学和老化药物显示出恢复免疫功能的前景.
结论:
- 了解免疫衰变对于对抗与年龄相关的疾病至关重要.
- 用纳米治疗药物向衰老细胞和增强免疫反应提供了潜在的治疗途径.
- 对老化剂和纳米疫苗的进一步研究可能会彻底改变抗衰老和抗癌疗法.
相关概念视频
Development of Immunocompetence
345
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
345
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558
Cell-mediated Immune Responses
68.9K
Overview
68.9K
Immunodeficiency Diseases
976
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
976
Cytotoxic T Cells-mediated Immune Response
972
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
972
Microorganisms in Medicine and Therapeutics
54
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
54


